FDA Approved: CYCLOPHOSPHAMIDE — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved BluePoint Laboratories' original ANDA for cyclophosphamide, establishing a generic version of the chemotherapy agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Breast Cancer
• Multiple Myeloma
• Neuroblastoma
• Non-hodgkin Lymphoma
• Ovarian Cancer
• Systemic Lupus Erythematosus

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

ORIG AP for CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE)